Anna Sparatore Selected Research

2-acetyloxybenzoic acid 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl ester

12/2012	Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
12/2012	Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo.
3/2012	Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14).
12/2010	Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Sparatore Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 03/2009
3	Pre-Eclampsia (Preeclampsia) 01/2021 - 07/2020
3	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2003
3	Necrosis 01/2020 - 01/2008
3	Parkinson Disease (Parkinson's Disease) 01/2013 - 06/2010
3	Glaucoma 03/2012 - 03/2009
3	Inflammation (Inflammations) 04/2011 - 03/2007
2	Osteolysis 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2021 - 12/2010
2	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 05/2014
2	Malaria 09/2015 - 10/2009
2	Alzheimer Disease (Alzheimer's Disease) 06/2015 - 08/2011
2	Body Weight (Weight, Body) 01/2012 - 05/2010
2	Ischemia 12/2010 - 01/2010
2	Neuroblastoma 06/2010 - 01/2010
1	Bone Diseases (Bone Disease) 01/2022
1	Chronic Disease (Chronic Diseases) 05/2014
1	Atherosclerosis 12/2012
1	Atherosclerotic Plaque (Atheroma) 12/2012
1	Thrombosis (Thrombus) 12/2012
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 12/2012
1	Epilepsy (Aura) 10/2012
1	Lung Neoplasms (Lung Cancer) 10/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2012
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 05/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2011
1	Cardiomyopathies (Cardiomyopathy) 01/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2010
1	Disease Progression 06/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2010

Drug/Important Bio-Agent (IBA)

8	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021 - 01/2010
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 12/2010
5	2- ((2,6- dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl esterIBA 01/2011 - 03/2007
5	Diclofenac (SR 38)FDA LinkGeneric 01/2011 - 03/2007
4	2-acetyloxybenzoic acid 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl esterIBA 12/2012 - 12/2010
3	ACS 84IBA 01/2013 - 01/2011
3	Levodopa (L Dopa)FDA LinkGeneric 01/2013 - 06/2010
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 10/2021 - 09/2015
2	Heme Oxygenase-1IBA 01/2021 - 07/2020
2	Therapeutic UsesIBA 12/2018 - 01/2013
2	Chloroquine (Aralen)FDA LinkGeneric 09/2015 - 10/2009
2	HomocysteineIBA 05/2014 - 08/2011
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2012 - 05/2010
2	Latanoprost (Xalatan)FDA Link 01/2011 - 01/2010
2	Sildenafil Citrate (Viagra)FDA Link 01/2011 - 06/2009
2	AcidsIBA 01/2011 - 01/2010
2	ThromboxanesIBA 12/2010 - 06/2009
2	S-sulindacIBA 05/2010 - 03/2009
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010 - 03/2009
2	Peroxidase (Myeloperoxidase)IBA 01/2008 - 03/2007
1	CD40 Ligand (CD40L)IBA 01/2022
1	AminesIBA 10/2021
1	Clofazimine (Lamprene)FDA Link 10/2021
1	A 7 (A-7)IBA 10/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	CytokinesIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	ACS94IBA 12/2018
1	Amyloid (Amyloid Fibrils)IBA 06/2015
1	Cholinesterases (Cholinesterase)IBA 06/2015
1	CX3C Chemokine Receptor 1IBA 12/2012
1	Apolipoproteins E (ApoE)IBA 12/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2012
1	GasotransmittersIBA 12/2012
1	Coloring Agents (Dyes)IBA 12/2012
1	ferric chlorideIBA 12/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2012
1	Histone Deacetylase InhibitorsIBA 10/2012
1	EnzymesIBA 10/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2012
1	Cisplatin (Platino)FDA LinkGeneric 10/2012
1	Transcription Factors (Transcription Factor)IBA 05/2012
1	Estrogens (Estrogen)FDA Link 05/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2012
1	Estrogen ReceptorsIBA 05/2012
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 01/2012
1	Neuroprotective AgentsIBA 08/2011
1	Quinacrine (Mepacrine)IBA 05/2011
1	dithiolIBA 01/2011
1	EstersIBA 01/2011
1	ThionesIBA 01/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011
1	Glutathione (Reduced Glutathione)IBA 12/2010
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 12/2010
1	Insulin (Novolin)FDA Link 12/2010
1	8-epi-prostaglandin F2alphaIBA 12/2010
1	Sulindac (Copal)FDA LinkGeneric 05/2010
1	Cadherins (E-Cadherin)IBA 05/2010
1	AntigensIBA 01/2010
1	Interferon-gamma (Interferon, gamma)IBA 01/2010

Therapy/Procedure

4	Therapeutics 10/2021 - 06/2010
1	Ligation 01/2021
1	Oral Administration 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Chemoprevention 05/2012
1	Intravitreal Injections 01/2010